OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Neurology Neurosurgery and Psychiatry is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
35 Processing speed (PS) improvement in alcohol related brain damage (ARBD)	116
Navigating the presymptomatic frontier in genetic ALS and FTD	93
#3115 Systematic review into the effects of sleep disorders on the development of PTSD	86
086 Long-term efficacy of fremanezumab in migraine patients with inadequate response to prior preventive medication classes	83
164 Progressive multifocal leukoencephalopathy (PML) following autologous periph- eral blood stem cell transplantation for multiple myeloma	81
West is best – a strongman with numb feet	79
094 Measuring neutralising antibodies (NAbs) to interferon-beta (IFNB) for multiple sclerosis (MS): a neglected practice?	76
099 Safety and effectiveness of dimethyl fumarate in multiple sclerosis patients treated over 5 years	74
005 Infusion associated reactions in ocrelizumab-treated multiple sclerosis patients	74
122 Neurological manifestations of haemophagocytic lymphohistiocytosis	70
White matter hyperintensities and brain microbleeds in ataxia-telangiectasia: the Cambridge cohort	68
102 The cost of misdiagnosis in POEMS syndrome	68
001 Machine learning accurately determines the population prevalence of Alzheimer’s disease based on microbiome profile	67
143 Catastrophising cognitions in patients with psychogenic non-epileptic seizures compared to patients with epilepsy	64
201 Management of an unusual presentation of spontaneous intracranial hypotension (SIH)	60
010 Safety and efficacy of long-term dimethyl fumarate treatment	60
184 Right data, right care	60
238 Cogniton and mood disorder in cervical dystonia	59
L-arginine and mitochondrial encephalomyopathy, lactic acidosis and stroke- like episodes (MELAS): a systematic review	57
12 A pilot investigation of interoceptive accuracy, awareness, and sensibility in functional neurological disorder	57
Improving clinical practice with an old friend from the neuroimmunology toolkit: acute corticosteroids in LGI1 antibody encephalitis	56
Multiple sclerosis reactivations after fingolimod discontinuation for pregnancy planning	56
Characterising ALS disease progression according to El Escorial and Gold Coast criteria	55
091 The East London Parkinson’s disease project – engaging a diverse population in research	54
175 A case series of anti-HMGCR immune mediated necrotizing myopathy: the West Midlands data	54

102 Levodopa and melanoma what do clinicians think?	53
059 Cannabidiol in refractory adult epilepsies: broadening the Lennox-Gastaut phenotype?	53
Improved naming in patients with Broca’s aphasia with tDCS	51
Haemorrhagic myelitis as a manifestation of MOG antibody-associated disease	51
117 Who is the culprit – the virus or the anti-virus?	51
Correction: The future of neuroprotection in stroke	50
226 Reduced synaptic density in progressive supranuclear palsy and corticobasal syndrome, revealed by [11C]UCB-J PET	50
Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis	47
091 CIDP mimic in a patient with HIV; An unusual presentation of POEMS syndrome	46
101 Motor and non-motor features of prodromal PD	45
003 Neuroanatomical signatures of genetic risk for Alzheimer’s disease in healthy adults	43
Plasma neurofilament light chain levels suggest neuroaxonal stability following therapeutic remyelination in people with multiple sclerosis	43
Neural (re)organisation of language and memory: implications for neuroplasticity and cognition	42
114 Effect of siponimod on cognitive processing speed in SPMS patients with active and non-active disease	42
Environmental risk scores of persistent organic pollutants associate with higher ALS risk and shorter survival in a new Michigan case/control cohort	42
Sodium valproate is associated with cortical thinning of disease-specific areas in juvenile myoclonic epilepsy	42
Early treatment of type II SMA slows rate of progression of scoliosis	41